Pasquale Martinelli

ORCID: 0000-0003-1911-7762
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Prenatal Screening and Diagnostics
  • Pregnancy and preeclampsia studies
  • HIV/AIDS Research and Interventions
  • Birth, Development, and Health
  • Preterm Birth and Chorioamnionitis
  • Neonatal Respiratory Health Research
  • Assisted Reproductive Technology and Twin Pregnancy
  • Pregnancy-related medical research
  • Ectopic Pregnancy Diagnosis and Management
  • Neonatal and fetal brain pathology
  • Maternal and fetal healthcare
  • Fetal and Pediatric Neurological Disorders
  • Gestational Diabetes Research and Management
  • HIV-related health complications and treatments
  • HIV, Drug Use, Sexual Risk
  • Toxoplasma gondii Research Studies
  • Congenital Heart Disease Studies
  • Maternal and Perinatal Health Interventions
  • HIV/AIDS drug development and treatment
  • Congenital Anomalies and Fetal Surgery
  • Syphilis Diagnosis and Treatment
  • Renal Diseases and Glomerulopathies
  • Congenital Diaphragmatic Hernia Studies
  • Celiac Disease Research and Management
  • Pregnancy and Medication Impact

University of Naples Federico II
2011-2022

IRCCS Materno Infantile Burlo Garofolo
2021

Federico II University Hospital
2009-2019

Thomas Jefferson University
2018-2019

Magna Graecia University
2019

University of Padua
2018-2019

Queen Charlotte's and Chelsea Hospital
2018

University of the Sacred Heart
2018

University of Udine
2018

University of Pennsylvania
2018

ABSTRACT Objectives Few data exist for counseling and perinatal management of women after an antenatal diagnosis early‐onset fetal growth restriction. Yet, the consequences preterm delivery its attendant morbidity both mother baby are far reaching. The objective this study was to describe mortality following restriction based on time delivery. Methods We report cohort outcomes a prospective multicenter randomized (Trial Randomized Umbilical Fetal Flow in Europe ( TRUFFLE )) performed 20...

10.1002/uog.13190 article EN Ultrasound in Obstetrics and Gynecology 2013-09-23

<h3>BACKGROUND</h3> Up to 50% of women with untreated coeliac disease experience miscarriage or an unfavourable outcome pregnancy. In most cases, after 6–12 months a gluten free diet, no excess pregnancy is observed. The prevalence undiagnosed among pregnant not known. <h3>AIM</h3> To determine the attending obstetrics-gynaecological department. <h3>METHODS</h3> Endomysial antibodies, which are specific and sensitive for disease, were evaluated in all obstetrics-gynaecology department large...

10.1136/gut.46.3.332 article EN Gut 2000-03-01

Placenta accreta is a rare and potentially life-threatening complication of pregnancy characterized by abnormal adherence the placenta to uterine wall. A previously scarred uterus or an site placentation in lower segment major risk factor. The aim this study was investigate change incidence associated factors along four decades, from 1970s 2000s, tertiary south Italian center. We analyzed all cases sample triennium for each decade. increased 0.12% during 1970s, 0.31% 2000s. During same...

10.1111/aogs.12080 article EN Acta Obstetricia Et Gynecologica Scandinavica 2013-01-24

<h3>Importance</h3> Spontaneous preterm birth is a major cause of perinatal morbidity and mortality. It unclear if cervical pessary can reduce the risk spontaneous delivery. <h3>Objective</h3> To test whether in asymptomatic women with singleton pregnancies no prior but short length on transvaginal ultrasound, use would rate at less than 34 weeks gestation. <h3>Design, Setting, Participants</h3> Parallel-group, nonblinded, randomized clinical trial conducted from March 1, 2016, to May 25,...

10.1001/jama.2017.18956 article EN JAMA 2017-12-19

Abstract Introduction Placenta accreta spectrum (PAS) carries a high burden of adverse maternal outcomes, especially significant blood loss, which can be life‐threatening. Different management strategies have been proposed but the association clinical risk factors and surgical options during cesarean delivery with loss is not clear. Material methods In this international multicenter study, 338 women PAS undergoing were included. Fourteen European one non‐European center (USA) provided cases...

10.1111/aogs.14103 article EN cc-by-nc-nd Acta Obstetricia Et Gynecologica Scandinavica 2021-02-03

In the recent TRUFFLE study, it appeared that, in pregnancies complicated by fetal growth restriction (FGR) between 26 and 32 weeks' gestation, monitoring of ductus venosus (DV) waveform combined with computed cardiotocography (CTG) to determine timing delivery increased chance infant survival without neurological impairment. However, concerns interpretation were raised, as DV be associated a non-significant increase death, some infants delivered after weeks, at which time study protocol no...

10.1002/uog.17433 article EN Ultrasound in Obstetrics and Gynecology 2017-02-09

Objective: To compare the mean transvaginal ultrasound (TVU) cervical length (CL) at midtrimester in screening for preterm birth vitro (IVF)-conceived twin pregnancies versus spontaneously-conceived pregnancies.Methods: This was a retrospective cohort study. Potential study subjects were identified time of routine second trimester fetal exam 18 0/7 to 23 6/7-week gestation. All women with diamniotic screened single TVU CL this trial included. Mean CLs compared between IVF-conceived and...

10.1080/14767058.2017.1378339 article EN The Journal of Maternal-Fetal & Neonatal Medicine 2017-09-11

To explore whether, in early fetal growth restriction (FGR), the longitudinal pattern of heart rate (FHR) short-term variation (STV) can be used to identify imminent distress and whether abnormalities FHR recordings are associated with 2-year infant outcome.The original TRUFFLE study assessed FGR, delivery based on ductus venosus (DV) Doppler pulsatility index (PI), combination safety-net criteria very low STV cardiotocography (CTG) and/or recurrent decelerations, could improve survival...

10.1002/uog.17215 article EN Ultrasound in Obstetrics and Gynecology 2016-08-03

Heart anomalies represent nearly one-third of all congenital anomalies. They are currently diagnosed using ultrasound. However, there is a strong need for more accurate and less operator-dependent screening method. Here we report metabolomics characterization maternal serum in order to describe metabolomic fingerprint representative heart anomalies.Metabolomic profiles were obtained from 350 mothers (280 controls 70 cases). Nine classification models built optimized. An ensemble model was...

10.1002/pd.5893 article EN Prenatal Diagnosis 2021-01-15
Coming Soon ...